99 results on '"Castellaneta A"'
Search Results
2. Navigating protection mechanisms and innovation models: A literature-based configurational framework of intellectual property strategies
3. Lipidomics reveals the reshaping of the mitochondrial phospholipid profile in cells lacking OPA1 and mitofusins
4. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
5. Species specific vulnerability to increased drought in temperate and Mediterranean floodplain forests
6. A targeted GC-MS/MS approach for the determination of eight sterols in microgreen and mature plant material
7. Functional Abdominal Pain Disorders and Constipation in Children on Gluten-Free Diet
8. Real-world experience with obeticholic acid in patients with primary biliary cholangitis
9. A comprehensive study of oleuropein aglycone isomers in olive oil by enzymatic/chemical processes and liquid chromatography-Fourier transform mass spectrometry integrated by H/D exchange
10. Culminating events and time working together in top management teams: Insights from private equity
11. Mode of Delivery and Risk of Celiac Disease: Risk of Celiac Disease and Age at Gluten Introduction Cohort Study
12. How does acquisition experience create value? Evidence from a regulatory change affecting the information environment
13. The effect of trade secret legal protection on venture capital investments: Evidence from the inevitable disclosure doctrine
14. THU-093 Biochemical response and liver stiffness variation over time predict liver-related events in patients with primary biliary cholangitis treated with Obeticholic acid
15. THU-101 Non-invasive tests for ruling out high-risk esophageal varices in patients with primary biliary cholangitis based on the cholestasis degree
16. LBP-038 Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort
17. Alternativa chirurgica mini-invasiva mediante l’utilizzo di impianti angolati dopo scollamento e dislocazione posteriore della membrana del seno
18. Effect of gonadectomy on HCC development in HBV transgenic mice
19. Improvement in the quality of the catering service of a rehabilitation hospital
20. Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
21. WED-260 - RESIST criteria accurately rule-out high-risk esophageal varices in patients with primary biliary cholangitis and compensated advanced chronic liver disease
22. OS-070 - Development and validation of a score predicting response to obeticholic acid in primary biliary cholangitis: the OCA response score (ORS)
23. OS-045 - Long-term real-world experience with obeticholic acid in primary biliary cholangitis: the Italian recapitulate study
24. Unexpected mediastinal mass in a liver transplanted patient
25. Transjugular intrahepatic portosystemic shunt for a patient with chylothorax in cryptogenic/metabolic cirrhosis
26. Long term renal safety of HCV direct acting antivirals in HCV positive kidney transplant recipients
27. Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantion
28. T01.01.18 RECURRENT OVERT GASTROINTESTINAL BLEEDING FROM ULCERATED GASTRIC ELASTOFIBROMA: UNPRECEDENTED PRESENTATION OF A RARE CONDITION
29. P.04.15 THE DISCOVERY OF A NOVEL GENETIC MUTATION IN BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS WIDENS THE INSIGHTS INTO DISORDER RELATED-MOLECULAR ANALYSIS
30. P.09.26 GENETIC AND METABOLIC RISK FACTOR FOR “DE NOVO” NON ALCOHOLIC FATTY LIVER DISEASE IN LIVER TRANSPLANT PATIENTS
31. Eosinophilic esophagitis associated with coeliac disease in children
32. Increased prevalence of abdominal pain-functional gastrointestinal disorders in pediatric celiac patients
33. OC.04.6 EARLY VIROLOGICAL RESPONSE IS THE MAIN PREDICTOR OF VIRAL ERADICATION IN HCV HAEMODIALYSIS PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
34. Immuno-modulating effects of Silibinin in liver transplant patients with HCV recurrence
35. Early virological response is the main predictors of viral eradication in HCV haemodialysis patients treated with pegylated interferon plus ribavirin
36. Impact of mTOR inhibition on expression of immune regulatory molecules by circulating dendritic cells and regulatory T cells in stable liver transplant patients
37. P.10.12: De Novo Non Alcoholic Fatty Liver Disease in Liver Transplanted Patients: A Systematic Review
38. P.09.1: A Case Report of Ustekinumab-Induced Acute Liver Injury
39. T-48 Efficacy and safety of intravenous silibinin in patients with HCV recurrence on the graft after liver transplantation (LT): a prospective, randomized, double-blind, placebo-controlled pilot study
40. P.02.14 ACUTE PANCREATITIS IN ELDERLY PATIENTS: A RETROSPECTIVE EVALUATION AT HOSPITAL ADMISSION
41. SAT-370 - Analysis of Predictive Factors of Non Response to Therapy in Autoimmune Hepatitis-Primary Biliary Cirrhosis Overlap Syndromes a Retrospective Singlecenter Experience
42. Tissue transglutaminase antibody cut-off and diagnosis of celiac disease
43. Mode of delivery and risk of celiac disease
44. Food safety in infancy: Are the Italian Paediatricians informed enough?
45. Slow achievement of HCV-RNA undetectability in cirrhotic patients treated with sofosbuvir + ribavirin: possible clinical implications in the liver transplant list management
46. Prevalence of FGIDs is increased in CD patient despite strict GFD
47. Urinary metabolome of children with autism and pervasive developmental disorder not otherwise specified
48. Infant feeding pattern, HLA status, and prevalence of celiac disease
49. PO64 COMPARATIVE STUDY OF HELICOBACTER PYLORI ERADICATION RATES WITH 10-DAY QUADRUPLE “CONCOMITANT” THERAPY AND SEQUENTIAL THERAPY IN CHILDREN
50. PO63 NATURAL HISTORY OF CELIAC DISEASE IN A LARGE COHORT OF 419 PROSPECTIVELY ENROLLED TYPE ONE DIABETES CHILDREN: A SINGLE CENTRE EXPERIENCE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.